August 2007, Volume 37 Number 8 , p 30 - 30 [FREE]



function openWeblink(url,target,width) { if (!width) width = '100%'; var newWindow; newWindow =,target,'width='+width+',height=480,status,resizable,titlebar,toolbar,scrollbars'); newWindow.focus(); } function set_JnlFullText_Print() { metaTag = document.createElement('meta'); metaTag.setAttribute('name','OvidPageId'); metaTag.setAttribute('content','JnlFullText_Print'); head = document.getElementsByTagName('head')[0]; head.appendChild(metaTag); return; } if (window.addEventListener) { // DOM Level 2 Event Module (NS 6+) window.addEventListener('onload',set_JnlFullText_Print(),false); } else if (window.attachEvent) { // IE 5+ Event Model window.attachEvent('onload',set_JnlFullText_Print); } // For anything else, just don't add the event Full Text   #header-block { display: none; } © 2007 Lippincott Williams & Wilkins, Inc. Volume 37(8), August 2007, p 30 Suppository prevents complications [Department: upFront: DRUG NEWS: POST-ERCP PANCREATITIS]

Acute ...


Acute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Administering indomethacin rectally before the procedure may lower the incidence and severity of post-ERCP pancreatitis, new research suggests.


The study involved 245 patients who received 100 mg of indomethacin in a rectal suppository and 245 who received an inert suppository immediately before a scheduled ERCP. Of the 442 who subsequently underwent ERCP, 22 (5%) developed pancreatitis. Of those 22 patients, 15 had received the placebo and 7 had received indomethacin. Those in the placebo group had a significantly higher incidence of pancreatitis that was moderate to severe.


Pancreatic duct injection is a known risk factor for post-ERCP pancreatitis. Among the 44 patients who underwent this procedure, only 1 from the indomethacin group developed pancreatitis, compared with 8 patients in the placebo group.


Researchers recommend using "this simple, cheap, and safe medication" to prevent post-ERCP pancreatitis or lessen its severity.



Sotoudehmanesh R, et al., Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP, American Journal of Gastroenterology, May 2007.